Back
Hanesbrands 10K Form
Buy
52
HBI
Hanesbrands
Last Price:
7.21
Seasonality Move:
-7.42%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-09 | 10Q | HBI/Hanesbrands Quarterly |
2023-08-10 | 10Q | HBI/Hanesbrands Quarterly |
2023-05-03 | 10Q | HBI/Hanesbrands Quarterly |
2022-11-09 | 10Q | HBI/Hanesbrands Quarterly |
2022-08-11 | 10Q | HBI/Hanesbrands Quarterly |
2022-05-06 | 10Q | HBI/Hanesbrands Quarterly |
Receive HBI News And Ratings
See the #1 stock for the next 7 days that we like better than HBI
HBI Financial Statistics
Sales & Book Value
Annual Sales: | $5.64B |
---|---|
Cash Flow: | $70.59M |
Price / Cash Flow: | 5.11 |
Annual Sales: | $0.18 |
Price / Book: | 39.37 |
Profitability
EPS (TTM): | -0.85000 |
---|---|
Net Income (TTM): | $-298.36M |
Gross Margin: | $1.9B |
Return on Equity: | -103.32% |
Return on Assets: | -5.18% |
Hanesbrands Earnings Forecast
Key Hanesbrands Financial Ratios
- The Gross Profit Margin over the past 22 years for HBI is 33.65%.
- The Selling, General & Administrative Expenses for HBI have been equal to 28.52% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is -1,553.39% of Operating Income.
- The Net Earning history of HBI is -0.31% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 14 years.
Hanesbrands Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Textiles, Apparel & Luxury Goods |
Sector: | Consumer Discretionary |
Current Symbol: | HBI |
CUSIP: | 410345 |
Website: | hanes.com |
Debt
Debt-to-Equity Ratio: | 50.75 |
---|---|
Current Ratio: | 1.46 |
Quick Ratio: | 0.45 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 14.97 |
HBI Technical Analysis vs Fundamental Analysis
Buy
52
Hanesbrands (HBI)
is a Buy
Is Hanesbrands a Buy or a Sell?
-
Hanesbrands stock is rated a Buy
The current Hanesbrands [HBI] share price is $7.21. The Score for HBI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.